Daily as of 3 Nov 16:00 ET
- Price
- below both $10.26 vs 50 $11.11 / 200 $10.76
- Projection
- 💀Death cross projected in 9 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 28 Apr 2026 · projected 22 bars out
ZVRA | Zevra TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$10.26
+$0.16 (+1.58%)
Zevra Therapeutics (ZVRA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2024.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Apr 2026, but the two have been closing on each other and a death cross is projected within 10 bars. Price sits below the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 16:00 ET
- Price
- below both $10.26 vs 50 $10.42 / 200 $11.64
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 28 Sep 2026 · projected 26 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 28 Sep 2026 | 💀Death | 4-hour | 26 bars out | Not tested |
| 8 Sep 2026 | 🟨Golden | 4-hour | 16 bars out | — |
| 28 Apr 2026 | 🟨Golden moderate | daily | 22 bars out | Not tested |
| 31 Dec 2025 | 💀Death steep | daily | 26 bars out | 2 bar cross test |
| 20 Jun 2025 | 🟨Golden moderate | daily | 18 bars out | Not tested |
About ZVRA
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$8.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2024
SectorHealthcare
Cap bandsmall